Curemark is a clinical-stage biopharmaceutical company dedicated to advancing innovative therapies for neurological and developmental disorders. Our diverse pipeline spans multiple critical areas of unmet need, including Autism Spectrum Disorder (ASD), Amyotrophic Lateral Sclerosis (ALS), Addiction, Attention-Deficit/Hyperactivity Disorder (ADHD), Schizophrenia, and Parkinson’s Disease.
At the heart of our mission is a commitment to addressing the root causes of these conditions, not just managing symptoms. Our lead investigational therapy targets key enzyme deficiencies associated with autism, offering a novel approach to treatment for a condition that affects millions worldwide.
Our pipeline reflects a science-driven, patient-first approach with a focus on discovering and developing transformative therapies for complex neurological conditions. By exploring the role of enzymes and their impact on brain function, Curemark aims to deliver targeted, effective treatments that improve patient outcomes.
With a commitment to scientific excellence, strategic collaboration, and a deep focus on patient well-being, Curemark is reshaping the future of neurological care. Our goal is to offer life-changing solutions for individuals living with autism, ALS, addiction, ADHD, schizophrenia, Parkinson’s disease, and other challenging conditions.
Stay connected with us as we continue to push the boundaries of discovery and bring new hope to patients, families, and caregivers. For more information, visit Curemark.com.
Company Details
- Employees
- 23
- Founded
- -
- Address
- 411 Theodore Fremd Ave.,
- Phone
- (914) 925-3450
- in****@****ark.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- curemark.com
- Keywords
- autism, neuro-developmental disorders, neurodegenerative disorders, enzymes, enzyme deficiencies, Autism Spectrum Disorder, CM-AT, ALS, Amyotrophic lateral sclerosis, addiction, Schizophrenia, Parkinson’s Disease, ADHD, Attention-deficit/hyperactivity disorder.
- HQ
- Rye, New York
Curemark, Llc Questions
Curemark, Llc's helpline number is (914) 925-3450
Curemark, Llc's website is curemark.com
Curemark, Llc's LinkedIn profile is https://www.linkedin.com/company/curemark-llc
Curemark, Llc has
23 employees.
View email and phone details for 23
employees at Curemark, Llc.
Curemark, Llc's industry is
Biotechnology Research
Curemark, Llc's top competitors are
Mysyara,
Scioto Biosciences, Inc,
Vertex Pharmaceuticals,
Yamo Pharmaceuticals,
Stalicla,
Earlitec Diagnostics, Inc.,
Sage Therapeutics,
Curemark®,
Motiv,
Global Institutional Advisors.
Curemark, Llc's support email address is info@curemark.com
Curemark, Llc's categories are Biotechnology Research
Curemark, Llc's founding year is 2006
